Market News Today — AI-Curated Stock & Crypto Headlines

MOUNTAIN VIEW, Calif., Aug. 21, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or “the Company”) (Nasdaq: RNXT), a life sciences …

Today, Aug. 19, 2026, Moderna's personalized cancer vaccine met its late-stage goal, with the company and Merck planning an FDA …

Aristotle Capital Management, LLC, an investment management company, released its “Core Equity Fund” Q2 2026 investor letter. A copy of …

Sweetgreen Inc. CEO Jonathan Neman says the cyclospora outbreak had an impact on the business but the US FDA now …

Steve Ostroff, Former Acting Commissioner of the FDA and Former Deputy Director of the National Center for Infectious Diseases at …

On this episode of Stock Movers: - RocketLab (RKLB) shares are higher this morning after rising Friday, following earnings from …

Bloomberg's Jessica Nix discusses the recent surge in foodborne illness outbreaks, attributing the increase partly to climate change and staffing …

Roivant Chief Executive Officer Matt Gline expects the FDA to approve the launch of a drug used to fight a …

Moderna’s mRNA-based flu vaccine, mFlusiva, is approved by the Food and Drug Administration for adults aged 50 and over.

After spending years and hundreds of millions of dollars, Johnson and Johnson has won FDA approval for its new surgical …

Things are going well for the pharmaceutical giant.

Vote is first step in broadening public access to so-called Wolverine peptide despite warnings about risks